Treating Life-Threatening Bleedings
eBook - ePub

Treating Life-Threatening Bleedings

Development of Recombinant Coagulation Factor VIIa

  1. 214 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Treating Life-Threatening Bleedings

Development of Recombinant Coagulation Factor VIIa

About this book

Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa provides a comprehensive understanding of the first new drug within the area of hemostasis, describing a new mechanism of action that has resulted in a modified concept of the whole hemostasis mechanism. As the treatment of life-threatening bleedings is a serious challenge for clinicians, this powerful and historic case study presents a detailed roadmap on how a new medicine can be developed, stressing the interaction between science and clinical work.The book stresses the importance of patient care in the learning process and provides new ideas on how to approach diseases and their treatment. Users will find a real world example that will act as a timely resource for those learning about, or engaged in, performing and supervising research across the biomedical sciences.- Documents the successful roadmap of the development of a new concept of treating major bleedings in the most life-threatening situations- Stresses the importance of the close connection between the clinic and research, describing how a new concept of hemostasis was revealed by careful clinical observation- Offers real-world research and development context for drug discovery, and for the treatment of hemophilia and other bleeding disorders

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Treating Life-Threatening Bleedings by Ulla Hedner in PDF and/or ePUB format, as well as other popular books in Medicine & Hematology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Academic Press
Year
2017
Print ISBN
9780128124390
eBook ISBN
9780128124406
Topic
Medicine
Subtopic
Hematology

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. About the Author
  6. Preface and Acknowledgments
  7. Chapter One. Classical Bleeding Disease (Hemophilia)
  8. Chapter Two. My Encounter With Hemophilia (1959–82)
  9. Chapter Three. The First Years at Novo Nordisk
  10. Chapter Four. The Development of Recombinant FVIIa (rFVIIa) (1985–88)
  11. Chapter Five. The Further Use and Development of rFVIIa (1989–96)
  12. Chapter Six. Legal Issues Regarding the Use of rFVIIa in Hemophilia Patients With Inhibitors
  13. Chapter Seven. Treatment With rFVIIa in Malmö (1996–99)
  14. Chapter Eight. The Launching and Uses of rFVIIa
  15. Chapter Nine. Mechanism of Action and Dosage
  16. Chapter Ten. The Continued Development of rFVIIa During the 2000s
  17. Chapter Eleven. Safety and Health Economy of rFVIIa
  18. Chapter Twelve. Three Different Descriptions of How rFVIIa Was Developed
  19. Chapter Thirteen. Some Final Remarks
  20. Index